牛叉诊股

[{"date":"2026.08.03","stock":"1.55","trade":"0.60","ind":"-0.96"},{"date":"2026.07.31","stock":"1.35","trade":"1.69","ind":"2.21"},{"date":"2026.07.30","stock":"-1.17","trade":"-1.97","ind":"-2.73"},{"date":"2026.07.29","stock":"0.51","trade":"0.51","ind":"1.10"},{"date":"2026.07.28","stock":"-0.66","trade":"-1.30","ind":"-4.52"},{"date":"2026.07.27","stock":"6.12","trade":"3.35","ind":"2.72"},{"date":"2026.07.24","stock":"-4.44","trade":"-4.36","ind":"-2.47"},{"date":"2026.07.23","stock":"0.15","trade":"0.60","ind":"0.44"},{"date":"2026.07.22","stock":"0.07","trade":"0.08","ind":"-1.42"},{"date":"2026.07.21","stock":"-1.17","trade":"-1.41","ind":"4.81"},{"date":"2026.07.20","stock":"-0.44","trade":"-0.39","ind":"-0.71"},{"date":"2026.07.17","stock":"-8.49","trade":"-7.15","ind":"-5.40"},{"date":"2026.07.16","stock":"-1.38","trade":"0.97","ind":"-1.97"},{"date":"2026.07.15","stock":"3.90","trade":"3.85","ind":"-0.97"},{"date":"2026.07.14","stock":"-0.34","trade":"2.69","ind":"2.77"},{"date":"2026.07.13","stock":"2.02","trade":"-0.42","ind":"-3.48"},{"date":"2026.07.10","stock":"2.94","trade":"3.20","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.78","trade":"-0.42","ind":"3.07"},{"date":"2026.07.08","stock":"1.30","trade":"-1.44","ind":"-1.87"},{"date":"2026.07.07","stock":"-6.66","trade":"-4.17","ind":"-1.24"},{"date":"2026.07.06","stock":"2.62","trade":"0.97","ind":"-1.16"}]

新华制药,深证成指,化学制药指数

压力支撑

该股压力位为13.60元，支撑位为13.45元。

[{"text":"\u538b\u529b\u4f4d","value":"13.60","date":1785686400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.45","date":1785686400,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.6资金面打败了11%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：08月03日 20:30

机构今日流向(万元)	-1140.84	机构5日流向(万元)	-4507.83
机构10日流向(万元)	-8320.97	机构20日流向(万元)	-11233.79

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少129.45万股，其中基金净减仓6家，主力净减仓8家，请投资者中长期谨慎为宜。

截止2025-12-31，共23家主力机构（基金20家，一般法人3家），持仓量总计25123.39万股，占流通A股51.00%
其中，基金持仓与2025-06-30相比：
增仓：3家，增持 13.60万股
减仓：9家，减持 18.80万股
新出现在主力名单中：8家，持有6.02万股
从主力名单中消失：16家，原持有87.81万股

消息面诊股

诊断结果：5.5消息面打败了17%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-05-27
一般消息	高管变动	因年龄原因	2026-03-31
利好	分红转增	10派1.5元(含税)	2026-03-30
一般消息	募资投向	公司购买资产	2026-02-07
一般消息	重大事项	关联交易	2025-10-25
一般消息	高管变动	取消监事会	2025-10-24
一般消息	高管变动	因个人原因	2025-09-05
一般消息	分红转增	不分配不转增	2025-08-27

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：5.9行业面打败了67%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.08.03","price":"-0.96","value":"0.60"},{"date":"2026.07.31","price":"2.21","value":"1.69"},{"date":"2026.07.30","price":"-2.73","value":"-1.97"},{"date":"2026.07.29","price":"1.10","value":"0.51"},{"date":"2026.07.28","price":"-4.52","value":"-1.30"},{"date":"2026.07.27","price":"2.72","value":"3.35"},{"date":"2026.07.24","price":"-2.47","value":"-4.36"},{"date":"2026.07.23","price":"0.44","value":"0.60"},{"date":"2026.07.22","price":"-1.42","value":"0.08"},{"date":"2026.07.21","price":"4.81","value":"-1.41"},{"date":"2026.07.20","price":"-0.71","value":"-0.39"},{"date":"2026.07.17","price":"-5.40","value":"-7.15"},{"date":"2026.07.16","price":"-1.97","value":"0.97"},{"date":"2026.07.15","price":"-0.97","value":"3.85"},{"date":"2026.07.14","price":"2.77","value":"2.69"},{"date":"2026.07.13","price":"-3.48","value":"-0.42"},{"date":"2026.07.10","price":"-2.29","value":"3.20"},{"date":"2026.07.09","price":"3.07","value":"-0.42"},{"date":"2026.07.08","price":"-1.87","value":"-1.44"},{"date":"2026.07.07","price":"-1.24","value":"-4.17"},{"date":"2026.07.06","price":"-1.16","value":"0.97"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	哈药股份	88.36%	6.21%	6.5分
2	-	15.81%	3.88%	分
3	永安药业	15.46%	-1.33%	6.0分
4	哈三联	12.48%	-10.13%	6.0分
5	普洛药业	8.94%	-1.42%	6.2分
6	恩华药业	8.70%	3.49%	6.1分
7	华邦健康	7.88%	5.85%	6.0分
8	健友股份	7.49%	5.82%	6.2分
9	鲁抗医药	7.34%	1.63%	6.2分
10	联环药业	7.24%	6.84%	5.5分
11	赛分科技	6.73%	-8.22%	5.7分
12	莎普爱思	6.56%	8.06%	6.0分
13	华北制药	4.74%	1.89%	5.8分
14	辰欣药业	4.37%	2.39%	4.9分
15	海正药业	4.29%	-3.71%	5.3分
16	博瑞医药	3.88%	-3.57%	4.5分
17	德展健康	3.70%	2.13%	5.2分
18	神奇制药	3.53%	3.53%	6.5分
19	中哲精化	3.51%	5.85%	6.3分
20	立方制药	3.36%	-1.34%	6.5分
21	ST人福	3.33%	4.43%	5.9分
22	华仁药业	3.03%	1.49%	5.6分
23	天新药业	2.73%	0.97%	5.2分
24	仙琚制药	2.60%	3.83%	6.1分
25	九典制药	2.60%	5.04%	5.4分
26	华特达因	2.44%	3.99%	5.3分
27	金陵药业	2.09%	3.41%	6.2分
28	新天地	1.97%	0.00%	5.3分
29	福安药业	1.90%	2.18%	5.7分
30	丰原药业	1.84%	4.14%	6.0分
31	海翔药业	1.66%	5.96%	6.0分
32	常山药业	1.61%	-5.90%	4.4分
33	川宁生物	1.60%	3.98%	5.8分
34	亿帆医药	1.37%	3.08%	5.9分
35	ST南新	1.07%	-2.22%	4.0分
36	广济药业	1.05%	5.66%	5.7分
37	兴齐眼药	1.02%	6.57%	6.3分
38	东北制药	0.87%	0.43%	5.4分
39	海普瑞	0.62%	1.78%	5.7分
40	国邦医药	0.56%	1.52%	5.1分
41	千红制药	0.43%	3.26%	6.3分
42	通化金马	0.40%	8.35%	6.0分
43	汉商集团	0.30%	8.36%	6.3分
44	东诚药业	0.15%	2.21%	6.4分
45	健康元	0.10%	0.88%	5.2分
46	迪哲医药	-0.14%	-12.68%	4.9分
47	华海药业	-0.18%	1.21%	6.2分
48	北大医药	-0.19%	2.52%	5.5分
49	丽珠集团	-0.55%	1.17%	5.9分
50	ST天圣	-0.59%	3.91%	5.7分
51	康芝药业	-0.61%	4.02%	5.6分
52	同和药业	-0.73%	3.64%	6.0分
53	国药现代	-0.78%	3.00%	5.4分
54	莱美药业	-0.80%	-3.33%	5.3分
55	赛托生物	-1.05%	8.33%	5.9分
56	石药创新	-1.12%	-0.27%	4.9分
57	山河药辅	-1.20%	3.36%	5.7分
58	卫信康	-1.66%	3.50%	5.6分
59	ST能特	-1.74%	-2.59%	5.0分
60	ST复华	-1.75%	9.19%	5.2分
61	罗欣药业	-1.90%	-3.93%	6.3分
62	新和成	-1.96%	2.04%	5.5分
63	富士莱	-2.11%	4.56%	5.7分
64	拓新药业	-2.17%	-0.82%	5.1分
65	复星医药	-2.28%	1.76%	5.4分
66	浙江医药	-2.47%	2.94%	5.6分
67	华润双鹤	-2.63%	-0.67%	5.3分
68	金城医药	-2.76%	2.92%	6.0分
69	本立科技	-2.85%	7.22%	6.1分
70	津药药业	-2.96%	-1.50%	5.6分
71	溢多利	-3.15%	5.23%	5.9分
72	-	-3.37%	4.65%	分
73	冀衡医药	-3.49%	5.59%	6.0分
74	润都股份	-3.94%	-2.24%	5.8分
75	奥锐特	-4.09%	5.65%	5.7分
76	民生健康	-4.25%	2.79%	5.6分
77	福元医药	-4.31%	1.11%	5.7分
78	誉衡药业	-4.95%	-0.69%	5.9分
79	力生制药	-5.08%	3.23%	5.3分
80	小方制药	-5.26%	2.93%	5.0分
81	ST惠程	-5.33%	0.28%	5.9分
82	仟源医药	-5.39%	5.07%	5.9分
83	向日葵	-5.56%	4.33%	4.5分
84	-	-5.72%	1.86%	分
85	-	-5.83%	2.75%	分
86	北陆药业	-6.10%	0.13%	5.8分
87	华东医药	-6.14%	-0.97%	5.1分
88	中关村	-6.28%	-2.66%	5.2分
89	东亚药业	-6.35%	10.17%	4.8分
90	新华制药	-6.59%	1.55%	6.0分
91	恒瑞医药	-6.64%	-1.12%	5.3分
92	泰恩康	-6.80%	3.71%	6.0分
93	复旦张江	-6.87%	1.10%	5.2分
94	凯因科技	-7.10%	4.78%	5.3分
95	诚意药业	-7.27%	1.28%	4.7分
96	天宇股份	-7.43%	1.15%	5.2分
97	西点药业	-7.43%	5.07%	6.0分
98	-	-7.45%	1.91%	分
99	吉贝尔	-7.68%	2.56%	5.7分
100	亚虹医药	-7.93%	-12.24%	4.5分
101	京新药业	-8.44%	-1.23%	5.3分
102	灵康药业	-8.54%	2.44%	5.6分
103	海森药业	-9.15%	3.31%	5.4分
104	-	-9.19%	1.21%	分
105	奥翔药业	-9.38%	3.11%	4.9分
106	百济神州	-9.87%	-8.89%	4.9分
107	微芯生物	-10.10%	-9.60%	4.8分
108	威尔药业	-11.03%	-1.25%	5.9分
109	海欣股份	-11.28%	2.23%	5.4分
110	ST诺泰	-11.45%	-0.82%	4.8分
111	盟科药业	-11.75%	-2.97%	5.3分
112	海南海药	-11.82%	6.98%	4.8分
113	尔康制药	-11.82%	2.00%	5.0分
114	易明医药	-11.91%	-0.43%	6.3分
115	-	-12.06%	3.74%	分
116	奥赛康	-12.19%	2.85%	6.5分
117	双鹭药业	-12.52%	1.62%	5.5分
118	海辰药业	-12.70%	-3.12%	5.2分
119	司太立	-12.93%	5.50%	5.3分
120	一品红	-13.38%	0.06%	5.5分
121	科伦药业	-13.41%	-13.01%	4.8分
122	百利天恒	-13.70%	-9.08%	5.0分
123	金石亚药	-14.00%	-4.23%	4.9分
124	美诺华	-14.06%	-8.23%	4.3分
125	舒泰神	-14.16%	-7.25%	4.4分
126	宣泰医药	-14.19%	-6.60%	5.1分
127	-	-14.27%	-6.23%	分
128	亚太药业	-14.41%	2.92%	5.3分
129	多瑞医药	-14.84%	1.03%	5.5分
130	海思科	-15.68%	-12.81%	5.9分
131	石药景峰	-16.04%	-5.79%	4.9分
132	亨迪药业	-16.18%	-3.49%	5.1分
133	悦康药业	-16.33%	0.83%	4.7分
134	共同药业	-16.52%	4.70%	6.4分
135	信立泰	-16.65%	-0.36%	5.2分
136	广生堂	-16.84%	-0.88%	4.4分
137	贝达药业	-18.24%	-7.01%	5.1分
138	-	-18.29%	-24.64%	分
139	益方生物	-18.52%	-21.77%	4.5分
140	汇宇制药	-18.64%	2.48%	5.4分
141	昂利康	-18.91%	0.24%	4.6分
142	艾力斯	-18.92%	-12.64%	5.8分
143	海创药业	-19.20%	-6.66%	4.6分
144	纳微科技	-19.26%	-6.36%	5.2分
145	翰宇药业	-20.78%	-6.28%	5.1分
146	上海谊众	-21.45%	0.80%	5.1分
147	键凯科技	-22.52%	-15.28%	4.4分
148	富祥股份	-23.26%	-11.86%	4.5分
149	苑东生物	-24.00%	-8.73%	4.9分
150	泽璟制药	-24.91%	-22.84%	4.9分
151	宏源药业	-25.72%	-1.44%	5.3分
152	圣诺生物	-25.83%	-5.05%	4.7分
153	华纳药厂	-25.89%	-7.31%	4.8分
154	首药控股	-26.05%	-12.92%	4.5分
155	科源制药	-32.04%	0.85%	4.7分
156	必贝特	-37.80%	-22.90%	4.6分
157	前沿生物	-38.02%	-17.21%	4.7分
158	花园生物	-38.63%	-4.13%	4.3分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.6基本面打败了38%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（55分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 66/216 ， 144/216。

[{"date":"2026-03-31","value":"1.59","vol":"0.45"},{"date":"2025-12-31","value":"5.68","vol":"-1.85"},{"date":"2025-09-30","value":"5.05","vol":"1.60"},{"date":"2025-06-30","value":"4.42","vol":"1.26"},{"date":"2025-03-31","value":"2.21","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.59	5.68	5.05	4.42	2.21
行业(%)	0.45	-1.85	1.60	1.26	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"18.20","vol":"50.98"},{"date":"2025-12-31","value":"18.78","vol":"49.96"},{"date":"2025-09-30","value":"19.17","vol":"49.79"},{"date":"2025-06-30","value":"20.04","vol":"49.69"},{"date":"2025-03-31","value":"18.75","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	18.20	18.78	19.17	20.04	18.75
行业(%)	50.98	49.96	49.79	49.69	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 78/216 ， 104/216。

[{"date":"2026-03-31","value":"-0.28","vol":"24.44"},{"date":"2025-12-31","value":"3.41","vol":"38.58"},{"date":"2025-09-30","value":"0.42","vol":"142.64"},{"date":"2025-06-30","value":"-1.98","vol":"79.18"},{"date":"2025-03-31","value":"-1.81","vol":"0.16"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-0.28	3.41	0.42	-1.98	-1.81
行业(%)	24.44	38.58	142.64	79.18	0.16

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-25.15","vol":"52.58"},{"date":"2025-12-31","value":"-38.32","vol":"-24.51"},{"date":"2025-09-30","value":"-25.53","vol":"3.72"},{"date":"2025-06-30","value":"-15.69","vol":"66.32"},{"date":"2025-03-31","value":"-20.99","vol":"-9.37"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-25.15	-38.32	-25.53	-15.69	-20.99
行业(%)	52.58	-24.51	3.72	66.32	-9.37

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/216 ， 7/216。

[{"date":"2026-03-31","value":"0.27","vol":"0.10"},{"date":"2025-12-31","value":"0.96","vol":"0.41"},{"date":"2025-09-30","value":"0.75","vol":"0.31"},{"date":"2025-06-30","value":"0.51","vol":"0.21"},{"date":"2025-03-31","value":"0.27","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.27	0.96	0.75	0.51	0.27
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.56","vol":"0.64"},{"date":"2025-12-31","value":"5.49","vol":"2.56"},{"date":"2025-09-30","value":"4.33","vol":"1.94"},{"date":"2025-06-30","value":"2.97","vol":"1.30"},{"date":"2025-03-31","value":"1.61","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.56	5.49	4.33	2.97	1.61
行业(次)	0.64	2.56	1.94	1.30	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-4.81","vol":"-2.75"},{"date":"2025-12-31","value":"10.63","vol":"16.48"},{"date":"2025-09-30","value":"4.14","vol":"4.59"},{"date":"2025-06-30","value":"10.22","vol":"2.93"},{"date":"2025-03-31","value":"0.35","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-4.81	10.63	4.14	10.22	0.35
行业	-2.75	16.48	4.59	2.93	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.20","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.27","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.20	-	0.27	-
行业	0.00	1.60	0.00	1.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/216 ， 17/216。

[{"date":"2026-03-31","value":"1.76","vol":"3.58"},{"date":"2025-12-31","value":"1.43","vol":"3.33"},{"date":"2025-09-30","value":"1.31","vol":"3.50"},{"date":"2025-06-30","value":"1.27","vol":"3.68"},{"date":"2025-03-31","value":"1.24","vol":"3.58"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.76	1.43	1.31	1.27	1.24
行业	3.58	3.33	3.50	3.68	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.18","vol":"2.94"},{"date":"2025-12-31","value":"0.93","vol":"2.71"},{"date":"2025-09-30","value":"0.85","vol":"2.75"},{"date":"2025-06-30","value":"0.85","vol":"2.90"},{"date":"2025-03-31","value":"0.84","vol":"2.81"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.18	0.93	0.85	0.85	0.84
行业	2.94	2.71	2.75	2.90	2.81

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/216 ， 55/216。

[{"date":"2026-03-31","value":"38.30","vol":"33.40"},{"date":"2025-12-31","value":"40.61","vol":"34.57"},{"date":"2025-09-30","value":"40.72","vol":"34.00"},{"date":"2025-06-30","value":"41.92","vol":"34.11"},{"date":"2025-03-31","value":"41.86","vol":"34.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	38.30	40.61	40.72	41.92	41.86
行业(%)	33.40	34.57	34.00	34.11	34.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.65","vol":"9.83"},{"date":"2025-12-31","value":"0.72","vol":"1.77"},{"date":"2025-09-30","value":"0.72","vol":"1.19"},{"date":"2025-06-30","value":"0.76","vol":"0.88"},{"date":"2025-03-31","value":"0.75","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.65	0.72	0.72	0.76	0.75
行业(%)	9.83	1.77	1.19	0.88	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"4.11","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.70","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.90","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[新华制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]